230 related articles for article (PubMed ID: 23587879)
1. DISC1-ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1.
Soda T; Frank C; Ishizuka K; Baccarella A; Park YU; Flood Z; Park SK; Sawa A; Tsai LH
Mol Psychiatry; 2013 Aug; 18(8):898-908. PubMed ID: 23587879
[TBL] [Abstract][Full Text] [Related]
2. Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression.
Sheppard CL; Lee LC; Hill EV; Henderson DJ; Anthony DF; Houslay DM; Yalla KC; Cairns LS; Dunlop AJ; Baillie GS; Huston E; Houslay MD
Cell Signal; 2014 Sep; 26(9):1958-74. PubMed ID: 24815749
[TBL] [Abstract][Full Text] [Related]
3. DISC1, PDE4B, and NDE1 at the centrosome and synapse.
Bradshaw NJ; Ogawa F; Antolin-Fontes B; Chubb JE; Carlyle BC; Christie S; Claessens A; Porteous DJ; Millar JK
Biochem Biophys Res Commun; 2008 Dec; 377(4):1091-6. PubMed ID: 18983980
[TBL] [Abstract][Full Text] [Related]
4. DISC1 variants 37W and 607F disrupt its nuclear targeting and regulatory role in ATF4-mediated transcription.
Malavasi EL; Ogawa F; Porteous DJ; Millar JK
Hum Mol Genet; 2012 Jun; 21(12):2779-92. PubMed ID: 22422769
[TBL] [Abstract][Full Text] [Related]
5. Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness.
Millar JK; Mackie S; Clapcote SJ; Murdoch H; Pickard BS; Christie S; Muir WJ; Blackwood DH; Roder JC; Houslay MD; Porteous DJ
J Physiol; 2007 Oct; 584(Pt 2):401-5. PubMed ID: 17823207
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 Receptor (D1R) Expression Is Controlled by a Transcriptional Repressor Complex Containing DISC1.
Suh Y; Noh SJ; Lee S; Suh BK; Lee SB; Choi J; Jeong J; Kim S; Park SK
Mol Neurobiol; 2019 Oct; 56(10):6725-6735. PubMed ID: 30915712
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.
Kuroiwa M; Snyder GL; Shuto T; Fukuda A; Yanagawa Y; Benavides DR; Nairn AC; Bibb JA; Greengard P; Nishi A
Psychopharmacology (Berl); 2012 Feb; 219(4):1065-79. PubMed ID: 21833500
[TBL] [Abstract][Full Text] [Related]
8. Structural interaction between DISC1 and ATF4 underlying transcriptional and synaptic dysregulation in an iPSC model of mental disorders.
Wang X; Ye F; Wen Z; Guo Z; Yu C; Huang WK; Rojas Ringeling F; Su Y; Zheng W; Zhou G; Christian KM; Song H; Zhang M; Ming GL
Mol Psychiatry; 2021 Apr; 26(4):1346-1360. PubMed ID: 31444471
[TBL] [Abstract][Full Text] [Related]
9. [
Ooms M; Tsujikawa T; Lohith TG; Mabins SN; Zoghbi SS; Sumitomo A; Jaaro-Peled H; Kimura Y; Telu S; Pike VW; Tomoda T; Innis RB; Sawa A; Fujita M
J Cereb Blood Flow Metab; 2019 Jul; 39(7):1306-1313. PubMed ID: 29430995
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
Lipina TV; Wang M; Liu F; Roder JC
Neuropharmacology; 2012 Mar; 62(3):1252-62. PubMed ID: 21376063
[TBL] [Abstract][Full Text] [Related]
11. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.
Morris JA; Kandpal G; Ma L; Austin CP
Hum Mol Genet; 2003 Jul; 12(13):1591-608. PubMed ID: 12812986
[TBL] [Abstract][Full Text] [Related]
12. Aggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington's disease.
Tanaka M; Ishizuka K; Nekooki-Machida Y; Endo R; Takashima N; Sasaki H; Komi Y; Gathercole A; Huston E; Ishii K; Hui KK; Kurosawa M; Kim SH; Nukina N; Takimoto E; Houslay MD; Sawa A
J Clin Invest; 2017 Apr; 127(4):1438-1450. PubMed ID: 28263187
[TBL] [Abstract][Full Text] [Related]
13. Disrupted-in-schizophrenia-1 (DISC1): a key susceptibility factor for major mental illnesses.
Sawamura N; Sawa A
Ann N Y Acad Sci; 2006 Nov; 1086():126-33. PubMed ID: 17185511
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine increases cell proliferation and regulates DISC1, PDE4B and NMDA receptor 2B expression in the hippocampus in chronic mild stress mice.
Zhang X; Li X; Li M; Ren J; Yun K; An Y; Lin L; Zhang H
Eur J Pharmacol; 2015 May; 755():58-65. PubMed ID: 25769842
[TBL] [Abstract][Full Text] [Related]
16. Uncovering the function of Disrupted in Schizophrenia 1 through interactions with the cAMP phosphodiesterase PDE4: Contributions of the Houslay lab to molecular psychiatry.
Brandon NJ
Cell Signal; 2016 Jul; 28(7):749-52. PubMed ID: 26432168
[TBL] [Abstract][Full Text] [Related]
17. DISC1 at 10: connecting psychiatric genetics and neuroscience.
Porteous DJ; Millar JK; Brandon NJ; Sawa A
Trends Mol Med; 2011 Dec; 17(12):699-706. PubMed ID: 22015021
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia.
Kassan A; Egawa J; Zhang Z; Almenar-Queralt A; Nguyen QM; Lajevardi Y; Kim K; Posadas E; Jeste DV; Roth DM; Patel PM; Patel HH; Head BP
J Neurophysiol; 2017 Jan; 117(1):436-444. PubMed ID: 27832597
[TBL] [Abstract][Full Text] [Related]
19. Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.
Jacobi AA; Halawani S; Lynch DR; Lin H
Neurosci Lett; 2019 Jan; 692():107-114. PubMed ID: 30391323
[TBL] [Abstract][Full Text] [Related]
20. Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes.
De Arcangelis V; Liu R; Soto D; Xiang Y
J Biol Chem; 2009 Dec; 284(49):33824-32. PubMed ID: 19801680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
